If you’ve been told you can’t take estrogen, the conversation usually turns to progestin-only pills. And that’s where the norethindrone vs drospirenone question comes up. Two very different mini-pills, both estrogen-free, both prescribed for similar reasons, but with meaningfully different safety profiles.
Most patients walk into the pharmacy assuming all mini-pills are basically the same. They aren’t. The older option (norethindrone, sold as Camila, Errin, and the brand Micronor) has been around since the 1970s. The newer one (drospirenone, branded Slynd) was FDA-approved in 2019 and behaves quite differently in the body.
So which is actually safer? The honest answer is, it depends on what you’re worried about. Clot risk, breakthrough bleeding, missed-dose forgiveness, blood pressure, potassium. They don’t rank the same way on every measure.
How Each Mini-Pill Actually Works
Norethindrone is a first-generation progestin derived from testosterone. At the mini-pill dose (0.35 mg), it works mainly by thickening cervical mucus and thinning the uterine lining. Ovulation suppression is inconsistent. That’s why the dosing window is so tight: take it more than three hours late and backup contraception is recommended.
Drospirenone is a fourth-generation progestin, chemically closer to spironolactone than to testosterone. The Slynd dose (4 mg) reliably suppresses ovulation in most cycles, similar to combined pills. It also has a 24-hour missed-dose window, which is a major practical difference.
In the norethindrone vs drospirenone comparison, that forgiveness window alone changes real-world effectiveness. People miss pills. Life happens.
Safety Profile: Where the Two Diverge
Blood clot risk
This is the biggest question for most patients switching off combined pills. Both mini-pills are considered low risk for venous thromboembolism (VTE) compared with estrogen-containing options, which is why they’re often prescribed to patients with migraine with aura, smokers over 35, or a personal history of clots.
That said, drospirenone in combined pills has been associated with slightly higher VTE rates than older progestins, per FDA communications. Whether that translates to the progestin-only Slynd formulation is still debated. Current data suggests the absolute risk is low, but it’s not zero, and prescribers tend to be cautious in patients with multiple clot risk factors. If you want a deeper look at how the progestin choice shifts clot risk, our breakdown of drospirenone vs levonorgestrel walks through the numbers.
Potassium and blood pressure
Drospirenone has anti-mineralocorticoid activity. Translation: it can raise potassium levels, especially if you’re also taking ACE inhibitors, ARBs, potassium-sparing diuretics, or NSAIDs daily. Mayo Clinic notes that prescribers often check a baseline potassium in patients with kidney issues or who take interacting medications.
Norethindrone doesn’t do this. If you have well-controlled hypertension or take NSAIDs regularly for chronic pain (and our article on naproxen vs ibuprofen for long-term use covers that territory), norethindrone may be the simpler choice.
Breakthrough bleeding
Both mini-pills cause irregular bleeding, particularly in the first few months. In clinical trials, drospirenone produced somewhat more predictable cycles than norethindrone, partly because it suppresses ovulation more reliably. Norethindrone users more commonly report spotting that doesn’t quite settle.
In practice, what I see most often: patients tolerate the bleeding for two or three cycles, and if it doesn’t normalize, they switch. That’s a reasonable approach.
Side Effects You Should Actually Watch For
The two pills share the typical progestin-only side effect list, but the frequency differs.
- Irregular bleeding or spotting (common with both, slightly more with norethindrone)
- Breast tenderness
- Headache
- Mood changes (drospirenone has more spironolactone-like effects, which can cut both ways)
- Acne (norethindrone, being androgenic, can occasionally worsen acne; drospirenone often improves it)
- Bloating or fluid retention (less with drospirenone due to its diuretic-like action)
- Elevated potassium (drospirenone only, mostly relevant with kidney issues or interacting drugs)
In the norethindrone vs drospirenone discussion, the acne and bloating piece matters more than people expect. Patients with PCOS or hormonal acne often prefer drospirenone for that reason.
Cost and Access
Norethindrone is dirt cheap. Generic versions run around $10 to $20 a month without insurance at most US pharmacies. Drospirenone (Slynd) is brand-only as of 2026 and typically costs $150 to $200 a month without coverage, though manufacturer savings programs exist.
For uninsured patients, that gap is real. Compare prices on generic norethindrone at edrugstore.com if cost is the deciding factor.
Who Should Pick Which?
Lean toward norethindrone if you:
- Have kidney issues or take ACE inhibitors, ARBs, or daily NSAIDs
- Want the cheapest reliable option
- Don’t mind setting a strict daily pill alarm
- Have a history of high potassium
Lean toward drospirenone if you:
- Forget pills occasionally and need the 24-hour window
- Have PCOS, hormonal acne, or premenstrual mood symptoms
- Want more predictable cycles
- Have normal kidney function and aren’t on potassium-raising medications
Neither is a clear "safer" winner across the board. The norethindrone vs drospirenone choice really comes down to your other medications, your kidney function, and how strict you can be with timing.
The Bottom Line
In the norethindrone vs drospirenone matchup, norethindrone is the older, cheaper, more rigid option that plays nicely with almost any other medication. Drospirenone is the more forgiving, more cycle-friendly option that demands attention to potassium and costs significantly more. Both are reasonable progestin-only choices for patients who can’t take estrogen.
Talk to your prescriber about your full medication list, your kidney labs, and how strict you can realistically be with a daily pill schedule. Bring up clot history on either side of your family. Your pharmacist can also flag any interactions worth a second look before you fill the prescription.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- FDA Slynd (drospirenone) prescribing information, official label data on drospirenone-only contraception.
- FDA drug safety communication on drospirenone and clot risk, regulatory analysis of VTE risk with drospirenone-containing pills.
- Mayo Clinic drospirenone monograph, clinical guidance on potassium monitoring and interactions.
- MedlinePlus norethindrone information, NIH-curated patient information on norethindrone use and side effects.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More